Industry Research Reports
Global Cyclic Peptide Service Market Research Report 2026
Industry: Service & Software
Published Date: 2026-01-16
Pages: 147 Pages
Report ld: 5695704
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
The global Cyclic Peptide Service market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Cyclic peptide services refer to service organizations that provide customized synthesis, analysis and other related services of cyclic peptides. Cyclic peptides are an important class of bioactive molecules with broad application prospects, such as drug research and development, biotechnology research and other fields.
The North American market for Cyclic Peptide Service is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Cyclic Peptide Service is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The global market for Cyclic Peptide Service in Biopharmaceutical is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 to 2032.
Major global companies of Cyclic Peptide Service include GenScript Biotech, Eurogentec, LifeTein, Biopharma PEG Scientific, AnaSpec, Scitide, JPT, CD ComputaBio, Creative Peptides, Macrocyclos, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Cyclic Peptide Service market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Cyclic Peptide Service. The Cyclic Peptide Service market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Cyclic Peptide Service market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Cyclic Peptide Service manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
MARKET SEGMENTATION
By Company
- GenScript Biotech
- Eurogentec
- LifeTein
- Biopharma PEG Scientific
- AnaSpec
- Scitide
- JPT
- CD ComputaBio
- Creative Peptides
- Macrocyclos
- Peptide Insitute
- Genepep
- Innovagen
- Bachem
- InnoPep
- Bio-Synthesis
- Biomatrik
- CPC Scientific
- Chinese Peptide
- Hangzhou All Peptide
- WuXi Discovery Services
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Cyclic Peptide Custom Synthesis Service
- Cyclic Peptide Structure Analysis Services
- Cyclic Peptide Biological Activity Evaluation Services
- Others
Segment by Application
- Biopharmaceutical
- Scientific Research
- Others
CHAPTER OUTLINE
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Cyclic Peptide Service companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cyclic Peptide Service Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Cyclic Peptide Custom Synthesis Service
1.2.3 Cyclic Peptide Structure Analysis Services
1.2.4 Cyclic Peptide Biological Activity Evaluation Services
1.2.5 Others
1.3 Market by Application
1.3.1 Global Cyclic Peptide Service Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Biopharmaceutical
1.3.3 Scientific Research
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cyclic Peptide Service Market Perspective (2021–2032)
2.2 Global Cyclic Peptide Service Growth Trends by Region
2.2.1 Global Cyclic Peptide Service Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Cyclic Peptide Service Historic Market Size by Region (2021–2026)
2.2.3 Cyclic Peptide Service Forecasted Market Size by Region (2027–2032)
2.3 Cyclic Peptide Service Market Dynamics
2.3.1 Cyclic Peptide Service Industry Trends
2.3.2 Cyclic Peptide Service Market Drivers
2.3.3 Cyclic Peptide Service Market Challenges
2.3.4 Cyclic Peptide Service Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cyclic Peptide Service Players by Revenue
3.1.1 Global Top Cyclic Peptide Service Players by Revenue (2021–2026)
3.1.2 Global Cyclic Peptide Service Revenue Market Share by Players (2021–2026)
3.2 Global Top Cyclic Peptide Service Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Cyclic Peptide Service Revenue
3.4 Global Cyclic Peptide Service Market Concentration Ratio
3.4.1 Global Cyclic Peptide Service Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cyclic Peptide Service Revenue in 2025
3.5 Global Key Players of Cyclic Peptide Service Head Offices and Areas Served
3.6 Global Key Players of Cyclic Peptide Service, Products and Applications
3.7 Global Key Players of Cyclic Peptide Service, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Cyclic Peptide Service Breakdown Data by Type
4.1 Global Cyclic Peptide Service Historic Market Size by Type (2021–2026)
4.2 Global Cyclic Peptide Service Forecasted Market Size by Type (2027–2032)
5 Cyclic Peptide Service Breakdown Data by Application
5.1 Global Cyclic Peptide Service Historic Market Size by Application (2021–2026)
5.2 Global Cyclic Peptide Service Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Cyclic Peptide Service Market Size (2021–2032)
6.2 North America Cyclic Peptide Service Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Cyclic Peptide Service Market Size by Country (2021–2026)
6.4 North America Cyclic Peptide Service Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Cyclic Peptide Service Market Size (2021–2032)
7.2 Europe Cyclic Peptide Service Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Cyclic Peptide Service Market Size by Country (2021–2026)
7.4 Europe Cyclic Peptide Service Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Cyclic Peptide Service Market Size (2021–2032)
8.2 Asia-Pacific Cyclic Peptide Service Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Cyclic Peptide Service Market Size by Region (2021–2026)
8.4 Asia-Pacific Cyclic Peptide Service Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Cyclic Peptide Service Market Size (2021–2032)
9.2 Latin America Cyclic Peptide Service Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Cyclic Peptide Service Market Size by Country (2021–2026)
9.4 Latin America Cyclic Peptide Service Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cyclic Peptide Service Market Size (2021–2032)
10.2 Middle East & Africa Cyclic Peptide Service Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Cyclic Peptide Service Market Size by Country (2021–2026)
10.4 Middle East & Africa Cyclic Peptide Service Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 GenScript Biotech
11.1.1 GenScript Biotech Company Details
11.1.2 GenScript Biotech Business Overview
11.1.3 GenScript Biotech Cyclic Peptide Service Introduction
11.1.4 GenScript Biotech Revenue in Cyclic Peptide Service Business (2021–2026)
11.1.5 GenScript Biotech Recent Development
11.2 Eurogentec
11.2.1 Eurogentec Company Details
11.2.2 Eurogentec Business Overview
11.2.3 Eurogentec Cyclic Peptide Service Introduction
11.2.4 Eurogentec Revenue in Cyclic Peptide Service Business (2021–2026)
11.2.5 Eurogentec Recent Development
11.3 LifeTein
11.3.1 LifeTein Company Details
11.3.2 LifeTein Business Overview
11.3.3 LifeTein Cyclic Peptide Service Introduction
11.3.4 LifeTein Revenue in Cyclic Peptide Service Business (2021–2026)
11.3.5 LifeTein Recent Development
11.4 Biopharma PEG Scientific
11.4.1 Biopharma PEG Scientific Company Details
11.4.2 Biopharma PEG Scientific Business Overview
11.4.3 Biopharma PEG Scientific Cyclic Peptide Service Introduction
11.4.4 Biopharma PEG Scientific Revenue in Cyclic Peptide Service Business (2021–2026)
11.4.5 Biopharma PEG Scientific Recent Development
11.5 AnaSpec
11.5.1 AnaSpec Company Details
11.5.2 AnaSpec Business Overview
11.5.3 AnaSpec Cyclic Peptide Service Introduction
11.5.4 AnaSpec Revenue in Cyclic Peptide Service Business (2021–2026)
11.5.5 AnaSpec Recent Development
11.6 Scitide
11.6.1 Scitide Company Details
11.6.2 Scitide Business Overview
11.6.3 Scitide Cyclic Peptide Service Introduction
11.6.4 Scitide Revenue in Cyclic Peptide Service Business (2021–2026)
11.6.5 Scitide Recent Development
11.7 JPT
11.7.1 JPT Company Details
11.7.2 JPT Business Overview
11.7.3 JPT Cyclic Peptide Service Introduction
11.7.4 JPT Revenue in Cyclic Peptide Service Business (2021–2026)
11.7.5 JPT Recent Development
11.8 CD ComputaBio
11.8.1 CD ComputaBio Company Details
11.8.2 CD ComputaBio Business Overview
11.8.3 CD ComputaBio Cyclic Peptide Service Introduction
11.8.4 CD ComputaBio Revenue in Cyclic Peptide Service Business (2021–2026)
11.8.5 CD ComputaBio Recent Development
11.9 Creative Peptides
11.9.1 Creative Peptides Company Details
11.9.2 Creative Peptides Business Overview
11.9.3 Creative Peptides Cyclic Peptide Service Introduction
11.9.4 Creative Peptides Revenue in Cyclic Peptide Service Business (2021–2026)
11.9.5 Creative Peptides Recent Development
11.10 Macrocyclos
11.10.1 Macrocyclos Company Details
11.10.2 Macrocyclos Business Overview
11.10.3 Macrocyclos Cyclic Peptide Service Introduction
11.10.4 Macrocyclos Revenue in Cyclic Peptide Service Business (2021–2026)
11.10.5 Macrocyclos Recent Development
11.11 Peptide Insitute
11.11.1 Peptide Insitute Company Details
11.11.2 Peptide Insitute Business Overview
11.11.3 Peptide Insitute Cyclic Peptide Service Introduction
11.11.4 Peptide Insitute Revenue in Cyclic Peptide Service Business (2021–2026)
11.11.5 Peptide Insitute Recent Development
11.12 Genepep
11.12.1 Genepep Company Details
11.12.2 Genepep Business Overview
11.12.3 Genepep Cyclic Peptide Service Introduction
11.12.4 Genepep Revenue in Cyclic Peptide Service Business (2021–2026)
11.12.5 Genepep Recent Development
11.13 Innovagen
11.13.1 Innovagen Company Details
11.13.2 Innovagen Business Overview
11.13.3 Innovagen Cyclic Peptide Service Introduction
11.13.4 Innovagen Revenue in Cyclic Peptide Service Business (2021–2026)
11.13.5 Innovagen Recent Development
11.14 Bachem
11.14.1 Bachem Company Details
11.14.2 Bachem Business Overview
11.14.3 Bachem Cyclic Peptide Service Introduction
11.14.4 Bachem Revenue in Cyclic Peptide Service Business (2021–2026)
11.14.5 Bachem Recent Development
11.15 InnoPep
11.15.1 InnoPep Company Details
11.15.2 InnoPep Business Overview
11.15.3 InnoPep Cyclic Peptide Service Introduction
11.15.4 InnoPep Revenue in Cyclic Peptide Service Business (2021–2026)
11.15.5 InnoPep Recent Development
11.16 Bio-Synthesis
11.16.1 Bio-Synthesis Company Details
11.16.2 Bio-Synthesis Business Overview
11.16.3 Bio-Synthesis Cyclic Peptide Service Introduction
11.16.4 Bio-Synthesis Revenue in Cyclic Peptide Service Business (2021–2026)
11.16.5 Bio-Synthesis Recent Development
11.17 Biomatrik
11.17.1 Biomatrik Company Details
11.17.2 Biomatrik Business Overview
11.17.3 Biomatrik Cyclic Peptide Service Introduction
11.17.4 Biomatrik Revenue in Cyclic Peptide Service Business (2021–2026)
11.17.5 Biomatrik Recent Development
11.18 CPC Scientific
11.18.1 CPC Scientific Company Details
11.18.2 CPC Scientific Business Overview
11.18.3 CPC Scientific Cyclic Peptide Service Introduction
11.18.4 CPC Scientific Revenue in Cyclic Peptide Service Business (2021–2026)
11.18.5 CPC Scientific Recent Development
11.19 Chinese Peptide
11.19.1 Chinese Peptide Company Details
11.19.2 Chinese Peptide Business Overview
11.19.3 Chinese Peptide Cyclic Peptide Service Introduction
11.19.4 Chinese Peptide Revenue in Cyclic Peptide Service Business (2021–2026)
11.19.5 Chinese Peptide Recent Development
11.20 Hangzhou All Peptide
11.20.1 Hangzhou All Peptide Company Details
11.20.2 Hangzhou All Peptide Business Overview
11.20.3 Hangzhou All Peptide Cyclic Peptide Service Introduction
11.20.4 Hangzhou All Peptide Revenue in Cyclic Peptide Service Business (2021–2026)
11.20.5 Hangzhou All Peptide Recent Development
11.21 WuXi Discovery Services
11.21.1 WuXi Discovery Services Company Details
11.21.2 WuXi Discovery Services Business Overview
11.21.3 WuXi Discovery Services Cyclic Peptide Service Introduction
11.21.4 WuXi Discovery Services Revenue in Cyclic Peptide Service Business (2021–2026)
11.21.5 WuXi Discovery Services Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
TABLE OF FIGURES
List of Tables
Table 1. Global Cyclic Peptide Service Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Key Players of Cyclic Peptide Custom Synthesis Service
Table 3. Key Players of Cyclic Peptide Structure Analysis Services
Table 4. Key Players of Cyclic Peptide Biological Activity Evaluation Services
Table 5. Key Players of Others
Table 6. Global Cyclic Peptide Service Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 7. Global Cyclic Peptide Service Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 8. Global Cyclic Peptide Service Market Size by Region (US$ Million), 2021–2026
Table 9. Global Cyclic Peptide Service Market Share by Region (2021–2026)
Table 10. Global Cyclic Peptide Service Forecasted Market Size by Region (US$ Million), 2027–2032
Table 11. Global Cyclic Peptide Service Market Share by Region (2027–2032)
Table 12. Cyclic Peptide Service Market Trends
Table 13. Cyclic Peptide Service Market Drivers
Table 14. Cyclic Peptide Service Market Challenges
Table 15. Cyclic Peptide Service Market Restraints
Table 16. Global Cyclic Peptide Service Revenue by Players (US$ Million), 2021–2026
Table 17. Global Cyclic Peptide Service Market Share by Players (2021–2026)
Table 18. Global Top Cyclic Peptide Service Players by Tier (Tier 1, Tier 2, and Tier 3), based on Cyclic Peptide Service Revenue, 2025
Table 19. Ranking of Global Top Cyclic Peptide Service Companies by Revenue (US$ Million) in 2025
Table 20. Global 5 Largest Players Market Share by Cyclic Peptide Service Revenue (CR5 and HHI), 2021–2026
Table 21. Global Key Players of Cyclic Peptide Service, Headquarters and Area Served
Table 22. Global Key Players of Cyclic Peptide Service, Products and Applications
Table 23. Global Key Players of Cyclic Peptide Service, Date of General Availability (GA)
Table 24. Mergers and Acquisitions, Expansion Plans
Table 25. Global Cyclic Peptide Service Market Size by Type (US$ Million), 2021–2026
Table 26. Global Cyclic Peptide Service Revenue Market Share by Type (2021–2026)
Table 27. Global Cyclic Peptide Service Forecasted Market Size by Type (US$ Million), 2027–2032
Table 28. Global Cyclic Peptide Service Revenue Market Share by Type (2027–2032)
Table 29. Global Cyclic Peptide Service Market Size by Application (US$ Million), 2021–2026
Table 30. Global Cyclic Peptide Service Revenue Market Share by Application (2021–2026)
Table 31. Global Cyclic Peptide Service Forecasted Market Size by Application (US$ Million), 2027–2032
Table 32. Global Cyclic Peptide Service Revenue Market Share by Application (2027–2032)
Table 33. North America Cyclic Peptide Service Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 34. North America Cyclic Peptide Service Market Size by Country (US$ Million), 2021–2026
Table 35. North America Cyclic Peptide Service Market Size by Country (US$ Million), 2027–2032
Table 36. Europe Cyclic Peptide Service Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 37. Europe Cyclic Peptide Service Market Size by Country (US$ Million), 2021–2026
Table 38. Europe Cyclic Peptide Service Market Size by Country (US$ Million), 2027–2032
Table 39. Asia-Pacific Cyclic Peptide Service Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
Table 40. Asia-Pacific Cyclic Peptide Service Market Size by Region (US$ Million), 2021–2026
Table 41. Asia-Pacific Cyclic Peptide Service Market Size by Region (US$ Million), 2027–2032
Table 42. Latin America Cyclic Peptide Service Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 43. Latin America Cyclic Peptide Service Market Size by Country (US$ Million), 2021–2026
Table 44. Latin America Cyclic Peptide Service Market Size by Country (US$ Million), 2027–2032
Table 45. Middle East & Africa Cyclic Peptide Service Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 46. Middle East & Africa Cyclic Peptide Service Market Size by Country (US$ Million), 2021–2026
Table 47. Middle East & Africa Cyclic Peptide Service Market Size by Country (US$ Million), 2027–2032
Table 48. GenScript Biotech Company Details
Table 49. GenScript Biotech Business Overview
Table 50. GenScript Biotech Cyclic Peptide Service Product
Table 51. GenScript Biotech Revenue in Cyclic Peptide Service Business (US$ Million), 2021–2026
Table 52. GenScript Biotech Recent Development
Table 53. Eurogentec Company Details
Table 54. Eurogentec Business Overview
Table 55. Eurogentec Cyclic Peptide Service Product
Table 56. Eurogentec Revenue in Cyclic Peptide Service Business (US$ Million), 2021–2026
Table 57. Eurogentec Recent Development
Table 58. LifeTein Company Details
Table 59. LifeTein Business Overview
Table 60. LifeTein Cyclic Peptide Service Product
Table 61. LifeTein Revenue in Cyclic Peptide Service Business (US$ Million), 2021–2026
Table 62. LifeTein Recent Development
Table 63. Biopharma PEG Scientific Company Details
Table 64. Biopharma PEG Scientific Business Overview
Table 65. Biopharma PEG Scientific Cyclic Peptide Service Product
Table 66. Biopharma PEG Scientific Revenue in Cyclic Peptide Service Business (US$ Million), 2021–2026
Table 67. Biopharma PEG Scientific Recent Development
Table 68. AnaSpec Company Details
Table 69. AnaSpec Business Overview
Table 70. AnaSpec Cyclic Peptide Service Product
Table 71. AnaSpec Revenue in Cyclic Peptide Service Business (US$ Million), 2021–2026
Table 72. AnaSpec Recent Development
Table 73. Scitide Company Details
Table 74. Scitide Business Overview
Table 75. Scitide Cyclic Peptide Service Product
Table 76. Scitide Revenue in Cyclic Peptide Service Business (US$ Million), 2021–2026
Table 77. Scitide Recent Development
Table 78. JPT Company Details
Table 79. JPT Business Overview
Table 80. JPT Cyclic Peptide Service Product
Table 81. JPT Revenue in Cyclic Peptide Service Business (US$ Million), 2021–2026
Table 82. JPT Recent Development
Table 83. CD ComputaBio Company Details
Table 84. CD ComputaBio Business Overview
Table 85. CD ComputaBio Cyclic Peptide Service Product
Table 86. CD ComputaBio Revenue in Cyclic Peptide Service Business (US$ Million), 2021–2026
Table 87. CD ComputaBio Recent Development
Table 88. Creative Peptides Company Details
Table 89. Creative Peptides Business Overview
Table 90. Creative Peptides Cyclic Peptide Service Product
Table 91. Creative Peptides Revenue in Cyclic Peptide Service Business (US$ Million), 2021–2026
Table 92. Creative Peptides Recent Development
Table 93. Macrocyclos Company Details
Table 94. Macrocyclos Business Overview
Table 95. Macrocyclos Cyclic Peptide Service Product
Table 96. Macrocyclos Revenue in Cyclic Peptide Service Business (US$ Million), 2021–2026
Table 97. Macrocyclos Recent Development
Table 98. Peptide Insitute Company Details
Table 99. Peptide Insitute Business Overview
Table 100. Peptide Insitute Cyclic Peptide Service Product
Table 101. Peptide Insitute Revenue in Cyclic Peptide Service Business (US$ Million), 2021–2026
Table 102. Peptide Insitute Recent Development
Table 103. Genepep Company Details
Table 104. Genepep Business Overview
Table 105. Genepep Cyclic Peptide Service Product
Table 106. Genepep Revenue in Cyclic Peptide Service Business (US$ Million), 2021–2026
Table 107. Genepep Recent Development
Table 108. Innovagen Company Details
Table 109. Innovagen Business Overview
Table 110. Innovagen Cyclic Peptide Service Product
Table 111. Innovagen Revenue in Cyclic Peptide Service Business (US$ Million), 2021–2026
Table 112. Innovagen Recent Development
Table 113. Bachem Company Details
Table 114. Bachem Business Overview
Table 115. Bachem Cyclic Peptide Service Product
Table 116. Bachem Revenue in Cyclic Peptide Service Business (US$ Million), 2021–2026
Table 117. Bachem Recent Development
Table 118. InnoPep Company Details
Table 119. InnoPep Business Overview
Table 120. InnoPep Cyclic Peptide Service Product
Table 121. InnoPep Revenue in Cyclic Peptide Service Business (US$ Million), 2021–2026
Table 122. InnoPep Recent Development
Table 123. Bio-Synthesis Company Details
Table 124. Bio-Synthesis Business Overview
Table 125. Bio-Synthesis Cyclic Peptide Service Product
Table 126. Bio-Synthesis Revenue in Cyclic Peptide Service Business (US$ Million), 2021–2026
Table 127. Bio-Synthesis Recent Development
Table 128. Biomatrik Company Details
Table 129. Biomatrik Business Overview
Table 130. Biomatrik Cyclic Peptide Service Product
Table 131. Biomatrik Revenue in Cyclic Peptide Service Business (US$ Million), 2021–2026
Table 132. Biomatrik Recent Development
Table 133. CPC Scientific Company Details
Table 134. CPC Scientific Business Overview
Table 135. CPC Scientific Cyclic Peptide Service Product
Table 136. CPC Scientific Revenue in Cyclic Peptide Service Business (US$ Million), 2021–2026
Table 137. CPC Scientific Recent Development
Table 138. Chinese Peptide Company Details
Table 139. Chinese Peptide Business Overview
Table 140. Chinese Peptide Cyclic Peptide Service Product
Table 141. Chinese Peptide Revenue in Cyclic Peptide Service Business (US$ Million), 2021–2026
Table 142. Chinese Peptide Recent Development
Table 143. Hangzhou All Peptide Company Details
Table 144. Hangzhou All Peptide Business Overview
Table 145. Hangzhou All Peptide Cyclic Peptide Service Product
Table 146. Hangzhou All Peptide Revenue in Cyclic Peptide Service Business (US$ Million), 2021–2026
Table 147. Hangzhou All Peptide Recent Development
Table 148. WuXi Discovery Services Company Details
Table 149. WuXi Discovery Services Business Overview
Table 150. WuXi Discovery Services Cyclic Peptide Service Product
Table 151. WuXi Discovery Services Revenue in Cyclic Peptide Service Business (US$ Million), 2021–2026
Table 152. WuXi Discovery Services Recent Development
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
Table 156. Authors List of This Report
List of Figures
Figure 1. Cyclic Peptide Service Picture
Figure 2. Global Cyclic Peptide Service Market Size Comparison by Type (US$ Million), 2021–2032
Figure 3. Global Cyclic Peptide Service Market Share by Type: 2025 vs 2032
Figure 4. Cyclic Peptide Custom Synthesis Service Features
Figure 5. Cyclic Peptide Structure Analysis Services Features
Figure 6. Cyclic Peptide Biological Activity Evaluation Services Features
Figure 7. Others Features
Figure 8. Global Cyclic Peptide Service Market Size by Application (US$ Million), 2021–2032
Figure 9. Global Cyclic Peptide Service Market Share by Application: 2025 vs 2032
Figure 10. Biopharmaceutical Case Studies
Figure 11. Scientific Research Case Studies
Figure 12. Others Case Studies
Figure 13. Cyclic Peptide Service Report Years Considered
Figure 14. Global Cyclic Peptide Service Market Size (US$ Million), Year-over-Year: 2021–2032
Figure 15. Global Cyclic Peptide Service Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 16. Global Cyclic Peptide Service Market Share by Region: 2025 vs 2032
Figure 17. Global Cyclic Peptide Service Market Share by Players in 2025
Figure 18. Global Cyclic Peptide Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 19. The Top 10 and 5 Players Market Share by Cyclic Peptide Service Revenue in 2025
Figure 20. North America Cyclic Peptide Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 21. North America Cyclic Peptide Service Market Share by Country (2021–2032)
Figure 22. United States Cyclic Peptide Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 23. Canada Cyclic Peptide Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 24. Europe Cyclic Peptide Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 25. Europe Cyclic Peptide Service Market Share by Country (2021–2032)
Figure 26. Germany Cyclic Peptide Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 27. France Cyclic Peptide Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 28. U.K. Cyclic Peptide Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 29. Italy Cyclic Peptide Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 30. Russia Cyclic Peptide Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 31. Ireland Cyclic Peptide Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 32. Asia-Pacific Cyclic Peptide Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 33. Asia-Pacific Cyclic Peptide Service Market Share by Region (2021–2032)
Figure 34. China Cyclic Peptide Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 35. Japan Cyclic Peptide Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 36. South Korea Cyclic Peptide Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 37. Southeast Asia Cyclic Peptide Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 38. India Cyclic Peptide Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 39. Australia & New Zealand Cyclic Peptide Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 40. Latin America Cyclic Peptide Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 41. Latin America Cyclic Peptide Service Market Share by Country (2021–2032)
Figure 42. Mexico Cyclic Peptide Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 43. Brazil Cyclic Peptide Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 44. Middle East & Africa Cyclic Peptide Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 45. Middle East & Africa Cyclic Peptide Service Market Share by Country (2021–2032)
Figure 46. Israel Cyclic Peptide Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 47. Saudi Arabia Cyclic Peptide Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 48. UAE Cyclic Peptide Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 49. GenScript Biotech Revenue Growth Rate in Cyclic Peptide Service Business (2021–2026)
Figure 50. Eurogentec Revenue Growth Rate in Cyclic Peptide Service Business (2021–2026)
Figure 51. LifeTein Revenue Growth Rate in Cyclic Peptide Service Business (2021–2026)
Figure 52. Biopharma PEG Scientific Revenue Growth Rate in Cyclic Peptide Service Business (2021–2026)
Figure 53. AnaSpec Revenue Growth Rate in Cyclic Peptide Service Business (2021–2026)
Figure 54. Scitide Revenue Growth Rate in Cyclic Peptide Service Business (2021–2026)
Figure 55. JPT Revenue Growth Rate in Cyclic Peptide Service Business (2021–2026)
Figure 56. CD ComputaBio Revenue Growth Rate in Cyclic Peptide Service Business (2021–2026)
Figure 57. Creative Peptides Revenue Growth Rate in Cyclic Peptide Service Business (2021–2026)
Figure 58. Macrocyclos Revenue Growth Rate in Cyclic Peptide Service Business (2021–2026)
Figure 59. Peptide Insitute Revenue Growth Rate in Cyclic Peptide Service Business (2021–2026)
Figure 60. Genepep Revenue Growth Rate in Cyclic Peptide Service Business (2021–2026)
Figure 61. Innovagen Revenue Growth Rate in Cyclic Peptide Service Business (2021–2026)
Figure 62. Bachem Revenue Growth Rate in Cyclic Peptide Service Business (2021–2026)
Figure 63. InnoPep Revenue Growth Rate in Cyclic Peptide Service Business (2021–2026)
Figure 64. Bio-Synthesis Revenue Growth Rate in Cyclic Peptide Service Business (2021–2026)
Figure 65. Biomatrik Revenue Growth Rate in Cyclic Peptide Service Business (2021–2026)
Figure 66. CPC Scientific Revenue Growth Rate in Cyclic Peptide Service Business (2021–2026)
Figure 67. Chinese Peptide Revenue Growth Rate in Cyclic Peptide Service Business (2021–2026)
Figure 68. Hangzhou All Peptide Revenue Growth Rate in Cyclic Peptide Service Business (2021–2026)
Figure 69. WuXi Discovery Services Revenue Growth Rate in Cyclic Peptide Service Business (2021–2026)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
Which companies rank high in the global Cyclic Peptide Service market?
The top companies in the global Cyclic Peptide Service market are GenScript Biotech、Eurogentec、LifeTein.
Related Reports
Global Cyclic Peptide Service Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Cyclic Peptide Service market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications.
Published Date: 2026-03-31
Pages: 172
USD 4900.00
(Single User License)
Global Cyclic Peptide Service Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Cyclic Peptide Service market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published Date: 2026-03-31
Pages: 117
USD 4250.00
(Single User License)
Cyclic Peptide Service - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Cyclic Peptide Service was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-01-19
Pages: 144
USD 3950.00
(Single User License)
Global Cyclic Peptide Service Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Cyclic Peptide Service market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-09-06
Pages: 120
USD 4250.00
(Single User License)
Global Cyclic Peptide Service Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Cyclic Peptide Service market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-08-05
Pages: 165
USD 4900.00
(Single User License)
Cyclic Peptide Service- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Cyclic Peptide Service was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-03-11
Pages: 148
USD 3950.00
(Single User License)
Global Cyclic Peptide Service Market Research Report 2025
The global market for Cyclic Peptide Service was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-03-11
Pages: 101
USD 2900.00
(Single User License)
Global and United States Cyclic Peptide Service Market Report & Forecast 2024-2030
Cyclic peptide services refer to service organizations that provide customized synthesis, analysis and other related services of cyclic peptides. Cyclic peptides are an important class of bioactive molecules with broad application prospects, such as drug research and development, biotechnology research and other fields.
Published Date: 2024-04-03
Pages: 139
USD 4350.00
(Single User License)
Cyclic Peptide Service- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Cyclic peptide services refer to service organizations that provide customized synthesis, analysis and other related services of cyclic peptides. Cyclic peptides are an important class of bioactive molecules with broad application prospects, such as drug research and development, biotechnology research and other fields.
Published Date: 2024-04-03
Pages: 150
USD 3950.00
(Single User License)
Global Cyclic Peptide Service Market Research Report 2024
Cyclic peptide services refer to service organizations that provide customized synthesis, analysis and other related services of cyclic peptides. Cyclic peptides are an important class of bioactive molecules with broad application prospects, such as drug research and development, biotechnology research and other fields.
Published Date: 2024-04-03
Pages: 102
USD 2900.00
(Single User License)
Global Cyclic Peptide Service Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Cyclic Peptide Service market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications.
Published: 2026-03-31
Pages: 172
USD 4900.00 (Single User License)Global Cyclic Peptide Service Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Cyclic Peptide Service market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published: 2026-03-31
Pages: 117
USD 4250.00 (Single User License)Cyclic Peptide Service - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Cyclic Peptide Service was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-01-19
Pages: 144
USD 3950.00 (Single User License)Global Cyclic Peptide Service Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Cyclic Peptide Service market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-09-06
Pages: 120
USD 4250.00 (Single User License)Global Cyclic Peptide Service Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Cyclic Peptide Service market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-08-05
Pages: 165
USD 4900.00 (Single User License)Cyclic Peptide Service- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Cyclic Peptide Service was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-03-11
Pages: 148
USD 3950.00 (Single User License)Global Cyclic Peptide Service Market Research Report 2025
The global market for Cyclic Peptide Service was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-03-11
Pages: 101
USD 2900.00 (Single User License)Global and United States Cyclic Peptide Service Market Report & Forecast 2024-2030
Cyclic peptide services refer to service organizations that provide customized synthesis, analysis and other related services of cyclic peptides. Cyclic peptides are an important class of bioactive molecules with broad application prospects, such as drug research and development, biotechnology research and other fields.
Published: 2024-04-03
Pages: 139
USD 4350.00 (Single User License)Cyclic Peptide Service- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Cyclic peptide services refer to service organizations that provide customized synthesis, analysis and other related services of cyclic peptides. Cyclic peptides are an important class of bioactive molecules with broad application prospects, such as drug research and development, biotechnology research and other fields.
Published: 2024-04-03
Pages: 150
USD 3950.00 (Single User License)Global Cyclic Peptide Service Market Research Report 2024
Cyclic peptide services refer to service organizations that provide customized synthesis, analysis and other related services of cyclic peptides. Cyclic peptides are an important class of bioactive molecules with broad application prospects, such as drug research and development, biotechnology research and other fields.
Published: 2024-04-03
Pages: 102
USD 2900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 2900.00
USD 4350.00
USD 5800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now